Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testosterone, cytochrome P450, and cardiac hypertrophy.

Thomas Thum1, Jürgen Borlak

  • 1Center of Drug Research and Medical Biotechnology, Fraunhofer Institute of Toxicology and Aerosol Research, Hannover, Germany.

FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology
|October 11, 2002
PubMed
Summary

Cardiac hypertrophy alters testosterone metabolism via changes in cytochrome P450 (CYP) mono-oxygenase expression. This study reveals key shifts in steroid metabolism critical for heart health during disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical plausibility of eggshell membrane proteins for osteoarthritis: a study of solubility, digestibility, and immune response.

Molecular and cellular biochemistry·2026
Same author

Distinct mechanistic pathways in mouse MASLD models: High-sucrose/starch versus high-fat, methionine- and choline-deficient diets.

The Journal of nutritional biochemistry·2026
Same author

Serial blood collection in anaesthetised rats: Enhancing animal welfare without the need for jugular vein catheterisation.

Regulatory toxicology and pharmacology : RTP·2025
Same author

Diclofenac Immune-Mediated Hepatitis: Identification of Innate and Adaptive Immune Responses at Clinically Relevant Doses.

International journal of molecular sciences·2025
Same author

Differentially expressed and alternately spliced genes as a novel tool for genotoxicity: a computerized study in ATT-myc transgenic mice for the recognition of genotoxic and non-genotoxic chemical.

Frontiers in genetics·2025
Same author

ATT-Myc Transgenic Mouse Model and Gene Expression Identify Genotoxic and Non-Genotoxic Chemicals That Accelerating Liver Tumor Growth in Short-Term Toxicity.

Biomedicines·2025

Area of Science:

  • Biochemistry
  • Cardiology
  • Endocrinology

Background:

  • Cytochrome P450 (CYP) mono-oxygenases are crucial for steroid metabolism.
  • Sex hormones may influence cardiac mass and physiology.
  • CYP activity is often altered in disease states.

Purpose of the Study:

  • To investigate alterations in CYP mono-oxygenase expression and testosterone metabolism in cardiac hypertrophy.
  • To examine the role of specific enzymes and the androgen receptor in diseased hearts.

Main Methods:

  • Analysis of CYP mono-oxygenase isoforms, steroid-metabolizing enzymes, and androgen receptor in normal and hypertrophic human hearts and spontaneously hypertensive rats (SHR).
  • Measurement of testosterone metabolism, dihydrotestosterone production, and lipid peroxidation.

Related Experiment Videos

  • Assessment of alpha-myosin heavy chain (α-MHC) expression and effects of finasteride and testosterone supplementation.

    • Main Results:

    • Increased and idiosyncratic testosterone metabolism observed in hypertrophic hearts, linked to altered CYP expression.
    • Upregulation of 5-alpha reductase and P450 aromatase gene expression, leading to enhanced dihydrotestosterone production.
    • Increased androgen receptor expression and lipid peroxidation in diseased hearts, with inhibition by CYP inactivation.
    • Repression of α-MHC in cardiac hypertrophy, restored by testosterone supplementation.

    Conclusions:

    • Heart-specific steroid metabolism is significantly altered in cardiac hypertrophy.
    • CYP mono-oxygenases and androgen metabolism play a critical role in the pathophysiology of cardiac hypertrophy.
    • Targeting these pathways may offer therapeutic potential for heart disease.